Recombinant Luteinizing Hormone (rLH) Induces Ovarian Angiogenesis In Vivo via Modulation of the Expression of Follicular Vascular Endothelial Growth Factor (VEGF)-A165 and Its Soluble Receptor sFlt-1/VEGFR-1 but not Placental Growth Factor (PlGF). A Prospective, Randomized, Double-Blind, Placebo-Controlled Study - Gutman, G.; Barak, V.; Maslovitz, S.; Amit, A.; Lessing, J.B.; Geva, E. (Fertility & Sterility, 2005)